Evogene Ltd.
A computational biology company using AI to develop life-science products.
EVGN | TA
Overview
Corporate Details
- ISIN(s):
- IL0011050551
- LEI:
- Country:
- Israel
- Address:
- 13 Gad Feinstein St., Park Rehovot, 7638517 Rehovot
- Website:
- https://evogene.com/
Description
Evogene Ltd. is a computational biology company that leverages artificial intelligence and big data to discover and develop novel life-science products. The company's proprietary Computational Predictive Biology (CPB) platform is designed to optimize the probability of success and reduce the time and cost of development. Evogene operates in the fields of human health, agriculture, and industrial applications. Its technology is organized into three AI-driven engines tailored for specific product types: MicroBoost AI for microbe-based products, ChemPass AI for small molecule-based products, and GeneRator AI for products based on genetic elements. The company's business model involves supporting subsidiary companies that focus on specific commercial fields, utilizing Evogene's technology to bring innovative products to market.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2020-11-04 16:59 |
Announces Closing of $12 Million Registered Direct Offering
|
English | 36.1 KB | ||
| 2020-11-03 10:25 |
SCHEDULE 13G-Alpha Capital Anstalt
|
English | 135.2 KB | ||
| 2020-11-03 10:25 |
SCHEDULE 13G-Alpha Capital Anstalt
|
English | 36.0 KB | ||
| 2020-11-03 01:51 |
Prospectus Supplement Dated October 30, 2020
|
English | 361.0 KB | ||
| 2020-11-03 01:51 |
Prospectus Supplement Dated October 30, 2020
|
English | 35.9 KB | ||
| 2020-11-02 14:59 |
Financial Results and Earnings Announcement Schedule for the Third Quarter of 2…
|
English | 213.4 KB | ||
| 2020-11-02 14:59 |
Financial Results and Earnings Announcement Schedule for the Third Quarter of 2…
|
English | 36.1 KB | ||
| 2020-10-31 00:14 |
6k-Prices $12 Million Registered Direct Offering
|
English | 298.3 KB | ||
| 2020-10-31 00:14 |
6k-Prices $12 Million Registered Direct Offering
|
English | 35.9 KB | ||
| 2020-10-30 15:59 |
Prices $12 Million Registered Direct Offering
|
English | 158.8 KB | ||
| 2020-10-30 15:59 |
Prices $12 Million Registered Direct Offering
|
English | 36.0 KB | ||
| 2020-10-29 13:59 |
positive results for LAV311 and LAV312 in the bio-fungicide program of its subs…
|
English | 395.2 KB | ||
| 2020-10-29 13:59 |
positive results for LAV311 and LAV312 in the bio-fungicide program of its subs…
|
English | 36.0 KB | ||
| 2020-10-20 15:59 |
Results of 2020 Annual General Meeting of Shareholders
|
English | 62.9 KB | ||
| 2020-10-20 15:59 |
Results of 2020 Annual General Meeting of Shareholders
|
English | 35.9 KB |
Automate Your Workflow. Get a real-time feed of all Evogene Ltd. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Evogene Ltd.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Evogene Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
